May 22, 2025
Snapshot Top 10: Dow Jones U.S. Pharmaceuticals Index



The Top 10 performing stocks in the Dow Jones U.S. Pharmaceuticals Index are shown for seven different investment strategies. Whether you are looking for value, growth or dividend stocks, or you want stocks that rank well overall, you can see the top 10 stock picks, together with how they rank on a scale of 1 to 100 from the perspective of different investment strategies. We have also added our newest Sentiment and 360° View ranks, which encapsulate the market voices of analysts and professional investors into a simple ranking for easily evaluating stocks. As an objective research provider, Obermatt has been refining its stock analysis algorithms for more than 10 years (no AI used here!)

Select any stock for the detailed analysis of that stock's performance across the different investment analyses. Please note that the Top 10 stocks focus only on Large to XX-Large companies.


What the six ranks mean

For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. The higher the rank, the better the stock performs than its peers. And, we do this for six investment strategies:

Value - shows how good of a value the stock is. Green is "inexpensive"; red is "expensive".

Growth - shows a company's growth potential. Green is "high growth" expected; red is "tough times ahead".

Safety - relates to the amount of debt a company has. Green is low debt level; red is high debt level.

Combined Financial - this isn't an average of the first three ranks but rather a consolidated view across several financial indicators. Green = good; red = tread carefully.

(NEW) Sentiment - quantifies professional analyst ratings and holdings as well as market pulse. Green = positive sentiment; red = skepticism (Only available to Premium Subscribers).

(NEW) 360° View - the ultimate rating with all financial and non-financial indicators.

Special Analysis: TOP 10 Dividend Investment Strategy

Many people ask for tips about dividend stocks. These are the Top 10 dividend stocks in the Dow Jones U.S. Pharmaceuticals Index as of May 22, 2025.

TOP 10 Dividend Investment Strategy Value Strategy DIVIDEND Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Pfizer (XXL, US)  Pharmaceuticals
1. Pfizer (XXL, US)   Pharmaceuticals 100 100 72 82
2. Bristol-Myers Squibb (XXL, US)  Pharmaceuticals
2. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 98 94 72 79
3. Merck & Co. (XXL, US)  Pharmaceuticals
3. Merck & Co. (XXL, US)   Pharmaceuticals 96 86 81 63
4. Johnson & Johnson (XXL, US)  Pharmaceuticals
4. Johnson & Johnson (XXL, US)   Pharmaceuticals 94 47 58 36
5. Phibro Animal (L, US)  Pharmaceuticals
5. Phibro Animal (L, US)   Pharmaceuticals 88 94 100 98
6. Zoetis (XL, US)  Pharmaceuticals
6. Zoetis (XL, US)   Pharmaceuticals 84 20 9 53
7. Eli Lilly (XXL, US)  Pharmaceuticals
7. Eli Lilly (XXL, US)   Pharmaceuticals 82 20 39 44

☀ This company has a special achievement which is documented on its stock research page.

May 22, 2025. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Obermatt 360° Investment Strategy

TOP 10 Obermatt 360° Investment Strategy 360° Strategy 360° VIEW Value Strategy VALUE Combined Strategy COMBINED Sentiment Strategy SENTIMENT
1. Phibro Animal (L, US)   Pharmaceuticals
1. Phibro Animal (L, US)   Pharmaceuticals 98 94 100 32
2. Pfizer (XXL, US)   Pharmaceuticals
2. Pfizer (XXL, US)   Pharmaceuticals 82 100 72 78
3. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
3. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 79 94 72 72
4. Prestige (L, US)   Pharmaceuticals
4. Prestige (L, US)   Pharmaceuticals 67 26 52 80
5. Merck & Co. (XXL, US)   Pharmaceuticals
5. Merck & Co. (XXL, US)   Pharmaceuticals 63 86 81 38
6. Amphastar (M, US)   Pharmaceuticals
6. Amphastar (M, US)   Pharmaceuticals 58 67 70 40
7. Zoetis (XL, US)   Pharmaceuticals
7. Zoetis (XL, US)   Pharmaceuticals 53 20 9 100
8. Supernus Pharma (M, US)   Pharmaceuticals
8. Supernus Pharma (M, US)   Pharmaceuticals 51 26 45 28
9. Pacira BioSciences (M, US)   Pharmaceuticals
9. Pacira BioSciences (M, US)   Pharmaceuticals 46 70 77 12
10. Eli Lilly (XXL, US)   Pharmaceuticals
10. Eli Lilly (XXL, US)   Pharmaceuticals 44 20 39 58

May 22, 2025. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Sentiment Investment Strategy

TOP 10 Sentiment Investment Strategy Sentiment Strategy SENTIMENT Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Zoetis (XL, US)   Pharmaceuticals
1. Zoetis (XL, US)   Pharmaceuticals 100 20 9 53
2. Prestige (L, US)   Pharmaceuticals
2. Prestige (L, US)   Pharmaceuticals 80 26 52 67
3. Pfizer (XXL, US)   Pharmaceuticals
3. Pfizer (XXL, US)   Pharmaceuticals 78 100 72 82
4. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
4. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 72 94 72 79
5. Eli Lilly (XXL, US)   Pharmaceuticals
5. Eli Lilly (XXL, US)   Pharmaceuticals 58 20 39 44
6. Amphastar (M, US)   Pharmaceuticals
6. Amphastar (M, US)   Pharmaceuticals 40 67 70 58
7. Merck & Co. (XXL, US)   Pharmaceuticals
7. Merck & Co. (XXL, US)   Pharmaceuticals 38 86 81 63
8. Phibro Animal (L, US)   Pharmaceuticals
8. Phibro Animal (L, US)   Pharmaceuticals 32 94 100 98
9. Johnson & Johnson (XXL, US)   Pharmaceuticals
9. Johnson & Johnson (XXL, US)   Pharmaceuticals 28 47 58 36
10. Supernus Pharma (M, US)   Pharmaceuticals
10. Supernus Pharma (M, US)   Pharmaceuticals 28 26 45 51

May 22, 2025. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value Investment Strategy Value Strategy VALUE Growth Strategy GROWTH Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Pfizer (XXL, US)   Pharmaceuticals
1. Pfizer (XXL, US)   Pharmaceuticals 100 27 72 82
2. Phibro Animal (L, US)   Pharmaceuticals
2. Phibro Animal (L, US)   Pharmaceuticals 94 85 100 98
3. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
3. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 94 61 72 79
4. Merck & Co. (XXL, US)   Pharmaceuticals
4. Merck & Co. (XXL, US)   Pharmaceuticals 86 51 81 63
5. Assertio Therapeutics (S, US)   Pharmaceuticals
5. Assertio Therapeutics (S, US)   Pharmaceuticals 72 17 49 30
6. Pacira BioSciences (M, US)   Pharmaceuticals
6. Pacira BioSciences (M, US)   Pharmaceuticals 70 25 77 46
7. Amphastar (M, US)   Pharmaceuticals
7. Amphastar (M, US)   Pharmaceuticals 67 17 70 58
8. Johnson & Johnson (XXL, US)   Pharmaceuticals
8. Johnson & Johnson (XXL, US)   Pharmaceuticals 47 45 58 36
9. Prestige (L, US)   Pharmaceuticals
9. Prestige (L, US)   Pharmaceuticals 26 61 52 67
10. Supernus Pharma (M, US)   Pharmaceuticals
10. Supernus Pharma (M, US)   Pharmaceuticals 26 35 45 51

May 22, 2025. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth Investment Strategy Growth Strategy GROWTH Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Phibro Animal (L, US)   Pharmaceuticals
1. Phibro Animal (L, US)   Pharmaceuticals 85 94 100 98
2. Eli Lilly (XXL, US)   Pharmaceuticals
2. Eli Lilly (XXL, US)   Pharmaceuticals 83 20 39 44
3. Prestige (L, US)   Pharmaceuticals
3. Prestige (L, US)   Pharmaceuticals 61 26 52 67
4. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
4. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 61 94 72 79
5. Merck & Co. (XXL, US)   Pharmaceuticals
5. Merck & Co. (XXL, US)   Pharmaceuticals 51 86 81 63
6. Zoetis (XL, US)   Pharmaceuticals
6. Zoetis (XL, US)   Pharmaceuticals 47 20 9 53
7. Johnson & Johnson (XXL, US)   Pharmaceuticals
7. Johnson & Johnson (XXL, US)   Pharmaceuticals 45 47 58 36
8. Supernus Pharma (M, US)   Pharmaceuticals
8. Supernus Pharma (M, US)   Pharmaceuticals 35 26 45 51
9. Pfizer (XXL, US)   Pharmaceuticals
9. Pfizer (XXL, US)   Pharmaceuticals 27 100 72 82

May 22, 2025. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety Investment Strategy Safety Strategy SAFETY Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Supernus Pharma (M, US)  Pharmaceuticals
1. Supernus Pharma (M, US)   Pharmaceuticals 100 26 45 51
2. Pacira BioSciences (M, US)  Pharmaceuticals
2. Pacira BioSciences (M, US)   Pharmaceuticals 91 70 77 46
3. Amphastar (M, US)  Pharmaceuticals
3. Amphastar (M, US)   Pharmaceuticals 84 67 70 58
4. Johnson & Johnson (XXL, US)  Pharmaceuticals
4. Johnson & Johnson (XXL, US)   Pharmaceuticals 67 47 58 36
5. Phibro Animal (L, US)  Pharmaceuticals
5. Phibro Animal (L, US)   Pharmaceuticals 67 94 100 98
6. Assertio Therapeutics (S, US)  Pharmaceuticals
6. Assertio Therapeutics (S, US)   Pharmaceuticals 66 72 49 30
7. Prestige (L, US)  Pharmaceuticals
7. Prestige (L, US)   Pharmaceuticals 58 26 52 67
8. Merck & Co. (XXL, US)  Pharmaceuticals
8. Merck & Co. (XXL, US)   Pharmaceuticals 54 86 81 63
9. Pfizer (XXL, US)  Pharmaceuticals
9. Pfizer (XXL, US)   Pharmaceuticals 50 100 72 82
10. Zoetis (XL, US)  Pharmaceuticals
10. Zoetis (XL, US)   Pharmaceuticals 41 20 9 53

May 22, 2025. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined Investment Strategy Combined Strategy COMBINED Value Strategy VALUE Growth Strategy GROWTH 360° Strategy 360° VIEW
1. Phibro Animal (L, US)  Pharmaceuticals
1. Phibro Animal (L, US)   Pharmaceuticals 100 94 85 98
2. Merck & Co. (XXL, US)  Pharmaceuticals
2. Merck & Co. (XXL, US)   Pharmaceuticals 81 86 51 63
3. Pacira BioSciences (M, US)  Pharmaceuticals
3. Pacira BioSciences (M, US)   Pharmaceuticals 77 70 25 46
4. Pfizer (XXL, US)  Pharmaceuticals
4. Pfizer (XXL, US)   Pharmaceuticals 72 100 27 82
5. Bristol-Myers Squibb (XXL, US)  Pharmaceuticals
5. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 72 94 61 79
6. Amphastar (M, US)  Pharmaceuticals
6. Amphastar (M, US)   Pharmaceuticals 70 67 17 58
7. Johnson & Johnson (XXL, US)  Pharmaceuticals
7. Johnson & Johnson (XXL, US)   Pharmaceuticals 58 47 45 36
8. Prestige (L, US)  Pharmaceuticals
8. Prestige (L, US)   Pharmaceuticals 52 26 61 67
9. Assertio Therapeutics (S, US)  Pharmaceuticals
9. Assertio Therapeutics (S, US)   Pharmaceuticals 49 72 17 30
10. Supernus Pharma (M, US)  Pharmaceuticals
10. Supernus Pharma (M, US)   Pharmaceuticals 45 26 35 51

May 22, 2025. Top 10s are published weekly following the . ( or for more stocks)


☀ This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards.

Top 10 Stocks from the purely fact-based Obermatt Method in the stock index Dow Jones U.S. Pharmaceuticals Index from May 22, 2025.

Today's Top 10
More Top Stocks
Your Watchlist

Top 10 Stock History D.J. US Pharmaceutical



Obermatt Portfolio Performance
We’re so convinced about our research, that we buy our stock tips.
See the performance of the Obermatt portfolio.